These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 32840620)

  • 21. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness analysis of mechanical thrombectomy in acute ischemic stroke.
    Patil CG; Long EF; Lansberg MG
    J Neurosurg; 2009 Mar; 110(3):508-13. PubMed ID: 19025358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cost-utility analysis: Mechanical thrombectomy plus thrombolysis in ischemic stroke due to large vessel occlusion in the public sector in Chile].
    Lenz-Alcayaga R; Paredes-Fernández D; Hernández-Sánchez K; Valencia-Zapata JE
    Medwave; 2021 Apr; 21(3):e8152. PubMed ID: 33955971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Thrombectomy With Stroke Outcomes Among Patient Subgroups: Secondary Analyses of the DEFUSE 3 Randomized Clinical Trial.
    Lansberg MG; Mlynash M; Hamilton S; Yeatts SD; Christensen S; Kemp S; Lavori PW; Ortega-Gutierrez S; Broderick J; Heit J; Marks MP; Albers GW;
    JAMA Neurol; 2019 Apr; 76(4):447-453. PubMed ID: 30688974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-Effectiveness of Tenecteplase Before Thrombectomy for Ischemic Stroke.
    Gao L; Moodie M; Mitchell PJ; Churilov L; Kleinig TJ; Yassi N; Yan B; Parsons MW; Donnan GA; Davis SM; Campbell BCV;
    Stroke; 2020 Dec; 51(12):3681-3689. PubMed ID: 33023423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-World Cost-Effectiveness of Late Time Window Thrombectomy for Patients With Ischemic Stroke.
    Gao L; Bivard A; Parsons M; Spratt NJ; Levi C; Butcher K; Kleinig T; Yan B; Dong Q; Cheng X; Lou M; Yin C; Chen C; Wang P; Lin L; Choi P; Miteff F; Moodie M
    Front Neurol; 2021; 12():780894. PubMed ID: 34970213
    [No Abstract]   [Full Text] [Related]  

  • 27. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of mechanical thrombectomy within 6 hours of acute ischaemic stroke in China.
    Pan Y; Cai X; Huo X; Zhao X; Liu L; Wang Y; Miao Z; Wang Y
    BMJ Open; 2018 Feb; 8(2):e018951. PubMed ID: 29472264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endovascular Treatment of Acute Ischemic Stroke.
    Silva GS; Nogueira RG
    Continuum (Minneap Minn); 2020 Apr; 26(2):310-331. PubMed ID: 32224754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary transfer of emergency stroke patients eligible for mechanical thrombectomy by air in rural England: economic evaluation and considerations.
    Coughlan D; McMeekin P; Flynn D; Ford GA; Lumley H; Burgess D; Balami J; Mawson A; Craig D; Rice S; White P
    Emerg Med J; 2021 Jan; 38(1):33-39. PubMed ID: 33172878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of endovascular thrombectomy with alteplase versus endovascular thrombectomy alone for acute ischemic stroke secondary to large vessel occlusion.
    Ye Z; Zhou T; Zhang M; Zhou J; Xie F; Hill MD; Smith EE; Busse JW; Zhang Y; Liu Y; Wang X; Ma Z; An Z
    CMAJ Open; 2023; 11(3):E443-E450. PubMed ID: 37192770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of endovascular therapy for acute ischemic stroke with large infarct in China.
    Pan Y; Huo X; Jin A; Nguyen TN; Ma G; Tong X; Zhang X; Gao F; Ma N; Mo D; Ren Z; Wang Y; Miao Z
    J Neurointerv Surg; 2024 Apr; 16(5):453-458. PubMed ID: 37328189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effective analysis of mechanical thrombectomy alone in the treatment of acute ischaemic stroke: a Markov modelling study.
    Han M; Qin Y; Tong X; Ji L; Zhao S; Liu L; Chen J; Liu A
    BMJ Open; 2022 Apr; 12(4):e059098. PubMed ID: 35387833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non-small Cell Lung Cancer in the Italian National Health Service.
    Armeni P; Borsoi L; Fornaro G; Jommi C; Grossi F; Costa F
    Clin Ther; 2020 May; 42(5):830-847. PubMed ID: 32354495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of Atezolizumab Plus Bevacizumab vs Sorafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma.
    Su D; Wu B; Shi L
    JAMA Netw Open; 2021 Feb; 4(2):e210037. PubMed ID: 33625508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanical thrombectomy for large vessel occlusion between 6 and 24 h: outcome comparison of DEFUSE-3/DAWN eligible versus non-eligible patients.
    Dittrich TD; Sporns PB; Kriemler LF; Rudin S; Nguyen A; Zietz A; Polymeris AA; Tränka C; Thilemann S; Wagner B; Altersberger VL; Piot I; Barinka F; Hänsel M; Gensicke H; Engelter ST; Lyrer PA; Sutter R; Nickel CH; Katan M; Peters N; Michels L; Kulcsár Z; Karwacki GM; Pileggi M; Cereda C; Wegener S; Bonati LH; Fischer U; Psychogios M; De Marchis GM
    Int J Stroke; 2023 Jul; 18(6):697-703. PubMed ID: 36367319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness analysis of endovascular treatment with or without intravenous thrombolysis in acute ischemic stroke.
    Qureshi AI; Akinci Y; Huang W; Ishfaq MF; Hassan AE; Siddiq F; Gomez CR
    J Neurosurg; 2023 Jan; 138(1):223-232. PubMed ID: 35901768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimized density and locations of stroke centers for improved cost effectiveness of mechanical thrombectomy in patients with acute ischemic stroke.
    Ennab Vogel N; Wester P; Andersson Granberg T; Levin LÅ
    J Neurointerv Surg; 2024 Jan; 16(2):156-162. PubMed ID: 37072170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.